TY - JOUR AU - Péterfi, Zoltán TI - A mikrobiom és a kardiovaszkuláris egészség JF - CARDIOLOGIA HUNGARICA J2 - CARDIOL HUNG VL - 54 PY - 2024 IS - 1 SP - 32 EP - 38 PG - 7 SN - 0133-5596 DO - 10.26430/CHUNGARICA.2024.54.1.32 UR - https://m2.mtmt.hu/api/publication/34728591 ID - 34728591 AB - A bél mikrobiom fontos szerepet játszik számos betegség kialakulásában vagy annak progressziójában. Egy kevésbé ismert terület a kardiovaszkuláris rendszer betegségei és a mikrobiom közötti kapcsolat, a bél–szív tengely és ateroszklerózis kapcsolata. A bél mikrobiom hatását különböző közvetítő molekulákon, mint a lipopoliszacharid, trimetilamin, fenilactetil-glutamin, rövid szénláncú zsírsavak, másodlagos epesavak, keresztül fejti ki. A legtöbb hatás, nem közvetlen, hanem az anyagcsere-folyamatok megváltoztatásán keresztül érvényesül és tartós folyamat eredménye, ezért vizsgálata és az összefüggések bizonyítása is nehézségekbe ütközik. A bél mikrobiom egyensúlyának helyreállítása segíthet a kóros folyamatok megállításában vagy azok visszafordításában. Jelen közleményben összefoglaljuk az eddigi ismereteinket a mikrobiom anyagcseretermékeinek kardiovaszkuláris rendszerre való hatásáról, valamint a rendelkezésünkre álló lehetőségeket a kóros hatások kivédése érdekében. LA - Hungarian DB - MTMT ER - TY - JOUR AU - El-Sayed, Mohamed Mahmoud AU - Mohak, Sidhesh AU - Gala, Dhir AU - Fabian, Reka AU - Péterfi, Zoltán AU - Fabian, Zsolt TI - The Role of the Intestinal Microbiome in Multiple Sclerosis—Lessons to Be Learned from Hippocrates JF - BIOLOGY-BASEL J2 - BIOLOGY-BASEL VL - 12 PY - 2023 IS - 12 PG - 26 SN - 2079-7737 DO - 10.3390/biology12121463 UR - https://m2.mtmt.hu/api/publication/34398321 ID - 34398321 N1 - * Megosztott szerzőség AB - Based on recent advances in research of chronic inflammatory conditions, there is a growing body of evidence that suggests a close correlation between the microbiota of the gastrointestinal tract and the physiologic activity of the immune system. This raises the idea that disturbances of the GI ecosystem contribute to the unfolding of chronic diseases including neurodegenerative pathologies. Here, we overview our current understanding on the putative interaction between the gut microbiota and the immune system from the aspect of multiple sclerosis, one of the autoimmune conditions accompanied by severe chronic neuroinflammation that affects millions of people worldwide. LA - English DB - MTMT ER - TY - JOUR AU - Rábai, Miklós AU - Sándor, Barbara AU - Magyar, Klára AU - Kenyeres, Péter AU - Várady, Edit AU - Tóth, Levente AU - Márton, Zsolt AU - Péterfi, Zoltán AU - Szabados, Eszter AU - Huszár, Judit AU - Tóth, Kálmán AU - Habon, Tamás AU - Halmosi, Róbert TI - Löffler endokarditisz talaján kialakult infektív endokarditisz esete JF - CARDIOLOGIA HUNGARICA J2 - CARDIOL HUNG VL - 53 PY - 2023 IS - Suppl. A SP - A339 EP - A339 SN - 0133-5596 UR - https://m2.mtmt.hu/api/publication/34306768 ID - 34306768 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Czakó, László AU - Dubravcsik, Zsolt AU - Gyökeres, Tibor AU - Hritz, István AU - Illés, Dóra AU - Madácsy, László AU - Nagy, András AU - Péterfi, Zoltán AU - Szepes, Zoltán AU - Szücs, Ákos AU - Vincze, Áron TI - A Belügyminisztérium egészségügyi szakmai irányelve az epeút- és epehólyag-gyulladás diagnosztikus kritériumairól és terápiájáról. Klinikai egészségügyi szakmai irányelv TS - Klinikai egészségügyi szakmai irányelv JF - EGÉSZSÉGÜGYI KÖZLÖNY J2 - EGÉSZSÉGÜGYI KÖZLÖNY VL - 73 PY - 2023 IS - 8 SP - 898 EP - 936 PG - 39 SN - 2063-1146 UR - https://m2.mtmt.hu/api/publication/34276104 ID - 34276104 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Kappéter, Ágnes AU - Sipos, Dávid AU - Varga, Adorján AU - Vigvári, Szabolcs József AU - Halda-Kiss, Bernadett AU - Péterfi, Zoltán TI - Migraine as a Disease Associated with Dysbiosis and Possible Therapy with Fecal Microbiota Transplantation JF - MICROORGANISMS J2 - MICROORGANISMS VL - 11 PY - 2023 IS - 8 PG - 14 SN - 2076-2607 DO - 10.3390/microorganisms11082083 UR - https://m2.mtmt.hu/api/publication/34095174 ID - 34095174 N1 - ISSN:2076-2607 AB - Migraine is a painful neurological condition characterized by severe pain on one or both sides of the head. It may be linked to changes in the gut microbiota, which are influenced by antibiotic use and other factors. Dysbiosis, which develops and persists as a result of earlier antibiotic therapy, changes the composition of the intestinal flora, and can lead to the development of various diseases such as metabolic disorders, obesity, hematological malignancies, neurological or behavioral disorders, and migraine. Metabolites produced by the gut microbiome have been shown to influence the gut–brain axis. The use of probiotics as a dietary supplement may reduce the number and severity of migraine episodes. Dietary strategies can affect the course of migraines and are a valuable tool for improving migraine management. With fecal microbiota transplantation, gut microbial restoration is more effective and more durable. Changes after fecal microbiota transplantation were studied in detail, and many data help us to interpret the successful interventions. The microbiological alteration of the gut microflora can lead to normalization of the inflammatory mediators, the serotonin pathway, and influence the frequency and intensity of migraine pain. LA - English DB - MTMT ER - TY - JOUR AU - Péterfi, Zoltán AU - Varga, Adorján AU - Vigvári, Szabolcs József AU - Sipos, Dávid TI - A széklettranszplantáció aktuális hazai helyzete JF - CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY / GASZTROENTEROLÓGIAI ÉS HEPATOLÓGIAI SZEMLE J2 - CENT EUR J GASTRO HEPATOL VL - 9 PY - 2023 IS - 2 SP - 59 EP - 62 PG - 4 SN - 2415-9107 DO - 10.33570/CEUJGH.9.2.59 UR - https://m2.mtmt.hu/api/publication/34025825 ID - 34025825 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Czakó, László AU - Gyökeres, Tibor Zoltán AU - Hritz, István AU - Madácsy, László AU - Illés, Dóra AU - Szepes, Zoltán AU - Dubravcsik, Zsolt AU - Péterfi, Zoltán AU - Nagy, András AU - Szűcs, Ákos AU - Vincze, Áron TI - Epeút- és epehólyag-gyulladás: diagnosztikus kritériumok és terápia [Cholangitis and cholecystitis: diagnostic criteria and management] JF - ORVOSI HETILAP J2 - ORV HETIL VL - 164 PY - 2023 IS - 20 SP - 770 EP - 787 PG - 18 SN - 0030-6002 DO - 10.1556/650.2023.32770 UR - https://m2.mtmt.hu/api/publication/33842885 ID - 33842885 N1 - Belgyógyászati Klinika, Gasztroenterológiai Osztály, Általános Orvostudományi Kar, Szegedi Tudományegyetem, Szeged, Hungary Gasztroenterológiai Osztály, ÉSzak-Pesti Centrumkórház - Honvédkórház, Budapest, Hungary Sebészeti, Transzplantációs és Gasztroenterológiai Klinika, Általános Orvostudományi Kar, Semmelweis Egyetem, Budapest, Hungary Endo-Kapszula Magánorvosi Centrum, Székesfehérvár, Hungary Gasztroenterológiai Osztály, Bács-Kiskun Megyei Oktatókórház, Kecskemét, Hungary I. Belgyógyászati Klinika, Általános Orvostudományi Kar, Pécsi Tudományegyetem, Pécs, Hungary Radiológiai Klinika, Általános Orvostudományi Kar, Szegedi Tudományegyetem, Szeged, Hungary Export Date: 7 September 2023 CODEN: ORHEA Correspondence Address: László, C.Pf. 469, Hungary; email: czako.laszlo@med.u-szeged.hu AB - In developed countries, diseases of the gallbladder and the biliary tract count as some of the most frequent gastrointestinal disorders. The inflammation of the gallbladder/biliary tree is a potentially severe, even lethal condition that requires rapid diagnosis and early multidisciplinary approach to be treated. Although the frequency of these diseases is high, the treatment is not unified in Hungary yet. The aim of the evidence-based recommendation is to clarify the diagnostic criteria and severity grading of these diseases and to highlight the indications and rules of proper application of the numerous available therapeutic interventions. The recent guideline is based on the consensus of the Board members of the Endoscopic Section of the Hungarian Gastroenterology Society in contribution with renown experts of surgery, infectology as well as interventional radiology and it counts as a clear and easy applicable guide during the all-day healthcare practice. Our guidelines are based on Tokyo guidelines established on the basis of the consensus reached in the International Consensus Meeting held in Tokyo which were revised in 2013 (TG13) and in 2018 (TG18). Orv Hetil. 2023; 164(20): 770-787. LA - Hungarian DB - MTMT ER - TY - JOUR AU - Varga, Adorján AU - Makszin, Lilla AU - Bufa, Anita AU - Sipos, Dávid AU - Kása, Péter AU - Pál, Szilárd AU - Rosenstiel, Philip AU - Sommer, Felix AU - Kocsis, Béla AU - Péterfi, Zoltán TI - Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer JF - FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY J2 - FRONT CELL INFECT MI VL - 13 PY - 2023 PG - 15 SN - 2235-2988 DO - 10.3389/fcimb.2023.1041384 UR - https://m2.mtmt.hu/api/publication/33588242 ID - 33588242 N1 - * Megosztott szerzőség LA - English DB - MTMT ER - TY - JOUR AU - Kanizsai, Andrea AU - Zavori, Laszlo AU - Molnár, Tihamér AU - Tőkés-Füzesi, Margit AU - Szalai, Zoltan AU - Berecz, Janos AU - Várnai, Réka AU - Péterfi, Zoltán AU - Schwarcz, Attila AU - Csécsei, Péter TI - Adverse Reactions after Booster SARS-CoV-2 Vaccination Have Less Impact on Antibody Response than after Basic Vaccination Scheme JF - VACCINES (BASEL) J2 - VACCINES-BASEL VL - 11 PY - 2023 IS - 1 PG - 10 SN - 2076-393X DO - 10.3390/vaccines11010182 UR - https://m2.mtmt.hu/api/publication/33567482 ID - 33567482 AB - Background: It is known that adverse reactions following SARS-CoV-2 vaccinations show a positive correlation with the subsequent antibody titer. However, it is not clear how the adverse reactions following the booster vaccination are related to the antibody levels that can be measured after a 3rd dose. The primary goal of this study was to investigate whether the adverse reactions following the booster vaccination show a correlation with subsequent antibody levels. Methods: Adverse reactions occurring within 7 days after the 3rd vaccination were recorded and the anti-SARS-CoV-2 spike protein immunoglobulin (Ig) level in the venous blood was measured on post-vaccination 14th, 60th and 120th days. Results: A total of 218 volunteers were included in the study. Main findings: (i) The adverse reactions that appeared after the booster dose did not show a positive correlation with the subsequent antibody level, except a correlation in the case of fever; (ii) there were more symptomatic patients in the group receiving heterologous booster vaccine, (iii) fever after the 2nd dose was independently associated with a reduction in the likelihood of COVID-19 positivity after the booster dose. Conclusion: No adverse reactions, but fever showed a correlation with the antibody level after the booster SARS-CoV-2 vaccine. LA - English DB - MTMT ER - TY - JOUR AU - Trøseid, Marius AU - Arribas, José R AU - Assoumou, Lambert AU - Holten, Aleksander Rygh AU - Poissy, Julien AU - Terzić, Vida AU - Mazzaferri, Fulvia AU - Baño, Jesús Rodríguez AU - Eustace, Joe AU - Hites, Maya AU - Joannidis, Michael AU - Paiva, José-Artur AU - Reuter, Jean AU - Püntmann, Isabel AU - Patrick-Brown, Thale D J H AU - Westerheim, Elin AU - Nezvalova-Henriksen, Katerina AU - Beniguel, Lydie AU - Dahl, Tuva Børresdatter AU - Bouscambert, Maude AU - Halanova, Monika AU - Péterfi, Zoltán AU - Tsiodras, Sotirios AU - Rezek, Michael AU - Briel, Matthias AU - Ünal, Serhat AU - Schlegel, Martin AU - Ader, Florence AU - Lacombe, Karine AU - Amdal, Cecilie Delphin AU - Rodrigues, Serge AU - Tonby, Kristian AU - Gaudet, Alexandre AU - Heggelund, Lars AU - Mootien, Joy AU - Johannessen, Asgeir AU - Møller, Jannicke Horjen AU - Pollan, Beatriz Diaz AU - Tveita, Anders Aune AU - Kildal, Anders Benjamin AU - Richard, Jean-Christophe AU - Dalgard, Olav AU - Simensen, Victoria Charlotte AU - Baldé, Aliou AU - de Gastines, Lucie AU - Del Álamo, Marta AU - Aydin, Burç AU - Lund-Johansen, Fridtjof AU - Trabaud, Mary-Anne AU - Diallo, Alpha AU - Halvorsen, Bente AU - Røttingen, John-Arne AU - Tacconelli, Evelina AU - Yazdanpanah, Yazdan AU - Olsen, Inge C AU - Costagliola, Dominique ED - Dyrhol-Riise, Anne Ma / Collaborator ED - Stiksrud, Birgitte / Collaborator ED - Jenum, Synne / Collaborator ED - MacPherson, Magnhild Eide / Collaborator ED - Aarskog, Nikolai Ravn / Collaborator ED - Røstad, Kjerstin / Collaborator ED - Skeie, Linda Gail / Collaborator ED - Dahl, Åsne / Collaborator ED - Steen, Jeanette Konstance / Collaborator ED - Nur, Sarah / Collaborator ED - Segers, Filip / Collaborator ED - Korsan, Katrine Andersen / Collaborator ED - Sethupathy, Ashwini / Collaborator ED - Sandstå, Ann Jorunn / Collaborator ED - Paulsen, Gunn-Janne / Collaborator ED - Ueland, Thor / Collaborator ED - Michelsen, Annika / Collaborator ED - Aukrust, Pål / Collaborator ED - Berdal, Jan Erik / Collaborator ED - Melkeraaen, Ingunn / Collaborator ED - Tollefsen, Merete Moen / Collaborator ED - Andreassen, Jessica / Collaborator ED - Dokken, Jannicke / Collaborator ED - Müller, Karl Erik / Collaborator ED - Woll, Bjørn Martin / Collaborator ED - Opsand, Hanne / Collaborator ED - Bogen, Mette / Collaborator ED - Rød, Linn-Therese / Collaborator ED - Steinsvik, Trude / Collaborator ED - Åsheim-Hansen, Bjørn / Collaborator ED - Bjerkreim, Randi Haukaas / Collaborator ED - Berg, Åse / Collaborator ED - Moen, Solfrid / Collaborator ED - Kvalheim, Stina / Collaborator ED - Strand, Kristian / Collaborator ED - Gravrok, Berit / Collaborator ED - Skogen, Vegard / Collaborator ED - Lorentzen, Elias Myrvoll / Collaborator ED - Schive, Simen Walberg / Collaborator ED - Rossvoll, Lasse / Collaborator ED - Hoel, Hedda / Collaborator ED - Engebråten, Simon / Collaborator ED - Martinsson, Mia Schie / Collaborator ED - Thallinger, Monica / Collaborator ED - Ådnanes, Elise / Collaborator ED - Hannula, Raisa / Collaborator ED - Bremnes, Nina / Collaborator ED - Liyanarachi, Kristin / Collaborator ED - Ehrnström, Birgitta / Collaborator ED - Kvalshaug, Martin / Collaborator ED - Berge, Kari / Collaborator ED - Bygdås, Marte / Collaborator ED - Gustafsson, Linda / Collaborator ED - AballiB, Saad / Collaborator ED - Strand, Marianne / Collaborator ED - Andersen, Britt / Collaborator ED - Aukrust, Pål / Collaborator ED - Barratt-Due, Andreas / Collaborator ED - Henriksen, Katerina Nezvalova / Collaborator ED - Kåsine, Trine / Collaborator ED - Dyrhol-Riise, Anne Ma / Collaborator ED - Berdal, Jan Erik / Collaborator ED - Favory, Raphaël / Collaborator ED - Nseir, Saad / Collaborator ED - Preau, Sebastien / Collaborator ED - Jourdain, Mercé / Collaborator ED - Ledoux, Geoffrey / Collaborator ED - Durand, Arthur / Collaborator ED - Houard, Marion / Collaborator ED - Moreau, Anne-Sophie / Collaborator ED - Rouzé, Anahita / Collaborator ED - Tortuyaux, Romain / Collaborator ED - Degouy, Guillaume / Collaborator ED - Levy, Clémentin / Collaborator ED - Liu, Vincent / Collaborator ED - Dognon, Nicolas / Collaborator ED - Mariller, Laure / Collaborator ED - Delcourte, Claire / Collaborator ED - Reguig, Zineb / Collaborator ED - Cerf, Amélie / Collaborator ED - Cuvelliez, Marie / Collaborator ED - Kipnis, Eric / Collaborator ED - Boyer-Beysserre, Marielle / Collaborator ED - Bignon, Anne / Collaborator ED - Parmentier, Laurie / Collaborator ED - Meddour, Damia / Collaborator ED - Frade, Sarah / Collaborator ED - Timsit, Jean-François / Collaborator ED - Peiffer-Smadja, Nathan / Collaborator ED - Wicky, Paul-Henri / Collaborator ED - De Montmollin, Etienne / Collaborator ED - Bouadma, Lila / Collaborator ED - Dessajan, Julien / Collaborator ED - Sonneville, Romain / Collaborator ED - Patrier, Juliette / Collaborator ED - Presente, Simona / Collaborator ED - Sylia, Zmihi / Collaborator ED - Rioux, Christophe / Collaborator ED - Thy, Michaël / Collaborator ED - Collias, Lio / Collaborator ED - Bouaraba, Yasmine / Collaborator ED - Dobremel, Nikita / Collaborator ED - Dureau, Anne-Florence / Collaborator ED - Oudeville, Pierre / Collaborator ED - Pointurier, Valentin / Collaborator ED - Rabouel, Yannick / Collaborator ED - Stiel, Laure / Collaborator ED - Alzina, Camille / Collaborator ED - Ramstein, Camille / Collaborator ED - Ait-Oufella, Hafid / Collaborator ED - Hamoudi, Fatima / Collaborator ED - Urbina, Thomas / Collaborator ED - Zerbib, Yoann / Collaborator ED - Maizel, Julien / Collaborator ED - Wilpotte, Celine / Collaborator ED - Piroth, Lionel / Collaborator ED - Blot, Mathieu / Collaborator ED - Sixt, Thibault / Collaborator ED - Moretto, Florian / Collaborator ED - Charles, Carole / Collaborator ED - Gohier, Sandrine / Collaborator ED - Roux, Damien / Collaborator ED - Le Breton, Camille / Collaborator ED - Gernez, Coralie / Collaborator ED - Thiry, Ingrid / Collaborator ED - Baboi, Loredana / Collaborator ED - Malvy, Denis / Collaborator ED - Boyer, Alexandre / Collaborator ED - Perreau, Pauline / Collaborator ED - Armellini, Maddalena / Collaborator ED - De Luca, Giulia / Collaborator ED - Di Pietro, Ospedale S M Massimo / Collaborator ED - Romanin, Benedetta / Collaborator ED - Brogi, Michela / Collaborator ED - Castelli, Francesco / Collaborator ED - Amadasi, Silvia / Collaborator ED - Barchiesi, Francesco / Collaborator ED - Canovari, Benedetta / Collaborator ED - Coppola, Nicola / Collaborator ED - Pisaturo, Mariantonietta / Collaborator ED - Russo, Antonio / Collaborator ED - Occhiello, Laura / Collaborator ED - Cataldo, Francesco / Collaborator ED - Rillo, Marta Mora / Collaborator ED - Queiruga, Javier / Collaborator ED - Seco, Enrique / Collaborator ED - Stewart, Stefan / Collaborator ED - Borobia, Alberto M / Collaborator ED - Moraga, Paloma / Collaborator ED - Prieto, Rocío / Collaborator ED - García, Irene / Collaborator ED - Rivera, Carlota / Collaborator ED - Narro, José Luis / Collaborator ED - Chacón, Natalia / Collaborator ED - de la Rosa, Sandra / Collaborator ED - Macías, María / Collaborator ED - Barrera, Lydia / Collaborator ED - Serna, Almudena / Collaborator ED - Palomo, Virginia / Collaborator ED - Sánchez, Maria Isabel García / Collaborator ED - Gutiérrez, David / Collaborator ED - Campos, Ana Silva / Collaborator ED - Garfia, Miguel Ángel Gómez / Collaborator ED - Toyos, Elvira Bonilla / Collaborator ED - Cabrera, Judith Sanabria / Collaborator ED - Lucena, María Isabel / Collaborator ED - Lapique, Eva Larranaga / Collaborator ED - Englert, Pierre / Collaborator ED - Khalil, Zineb / Collaborator ED - Jacobs, Frédérique / Collaborator ED - Malaise, Justine / Collaborator ED - Mukangenzi, Odette / Collaborator ED - Smissaert, Cinderella / Collaborator ED - Hildebrand, Marc / Collaborator ED - Martiny, Delphine / Collaborator ED - Vervacke, Audrey / Collaborator ED - Scarnière, Axelle / Collaborator ED - Yin, Nicolas / Collaborator ED - Michel, Charlotte / Collaborator ED - Seyler, Lucie / Collaborator ED - Allard, Sabine / Collaborator ED - Van Laethem, Johan / Collaborator ED - Verschelden, Gil / Collaborator ED - Meeuwissen, Annelies / Collaborator ED - De Waele, Alex / Collaborator ED - Van Buggenhout, Virgini / Collaborator ED - Monteyne, Dora / Collaborator ED - Noppe, Nils / Collaborator ED - Belkhir, Leila / Collaborator ED - Yombi, Jean Cyr / Collaborator ED - De Greef, Julien / Collaborator ED - Mesland, Jean Baptiste / Collaborator ED - De Ghellinck, Léopold / Collaborator ED - Kin, Valérie / Collaborator ED - D'Aoust, Céline / Collaborator ED - Bouvier, Anne / Collaborator ED - Dekeister, Anne- Charlotte / Collaborator ED - Hawia, Estelle / Collaborator ED - Gaillet, Adeline / Collaborator ED - Deshorme, Hélène / Collaborator ED - Halleux, Severine / Collaborator ED - Galand, Vanessa / Collaborator ED - Roncon-Albuquerque, Roberto / Collaborator ED - Santos, Luís Linhares / Collaborator ED - Vieira, César Burgi / Collaborator ED - Magalhaes, Rosana / Collaborator ED - Ferreira, Sónia / Collaborator ED - Bernardo, Mariana / Collaborator ED - Jackson, Arthur / Collaborator ED - Sadlier, Corinna / Collaborator ED - O'Connell, Sarah / Collaborator ED - Blair, Matthew / Collaborator ED - Manning, Edmund / Collaborator ED - Cusack, Fiona / Collaborator ED - Kelly, Niamh / Collaborator ED - Stephenson, Hannah / Collaborator ED - Keane, Ruben / Collaborator ED - Murphy, Aisling / Collaborator ED - Cunnane, Michele / Collaborator ED - Keane, Fionnuala / Collaborator ED - O'Regan, Mary-Claire / Collaborator ED - de Barra, Eoghan / Collaborator ED - Bellone, Aimee McGreal / Collaborator ED - O'Regan, Siobhan / Collaborator ED - Carey, Patrick / Collaborator ED - Harte, Jeffrey / Collaborator ED - Coakley, Peter / Collaborator ED - Heeney, Aoife / Collaborator ED - Ryan, Dorothy / Collaborator ED - Curley, Gerard / Collaborator ED - McConkey, Samuel / Collaborator ED - Sulaiman, Imran / Collaborator ED - Costello, Richard / Collaborator ED - McNally, Cora / Collaborator ED - Foley, Claire / Collaborator ED - Trainor, Sophie / Collaborator ED - Jacob, Benson / Collaborator ED - Vengathodi, Suchitra / Collaborator ED - Kent, Brian / Collaborator ED - Bergin, Colm / Collaborator ED - Townsend, Liam / Collaborator ED - Kerr, Colm / Collaborator ED - Panti, Nalini / Collaborator ED - Sanz, Alberto Garcia / Collaborator ED - Benny, Binny / Collaborator ED - Dea, Edel O / Collaborator ED - Galvin, Niamh / Collaborator ED - Burke, Claire / Collaborator ED - Galvin, Aisling / Collaborator ED - Aisiyabi, Sara / Collaborator ED - Lobo, Deepanjali / Collaborator ED - Laffey, John / Collaborator ED - McNicolas, Bairbre / Collaborator ED - Cosgrave, David / Collaborator ED - Sheehan, J R / Collaborator ED - Nita, Ciprian / Collaborator ED - Hanley, Ciara / Collaborator ED - Kelly, Claire / Collaborator ED - Kernan, Maeve / Collaborator ED - Murray, Jonathan / Collaborator ED - Staub, Thérèse / Collaborator ED - Henin, Thomas / Collaborator ED - Damilot, Gaelle / Collaborator ED - Bintener, Tania / Collaborator ED - Colling, Joelle / Collaborator ED - Ferretti, Christian / Collaborator ED - Werer, Christophe / Collaborator ED - Stammet, Pascal / Collaborator ED - Braquet, Pierre / Collaborator ED - Arendt, Vic / Collaborator ED - Calvo, Esther / Collaborator ED - Michaux, Christian / Collaborator ED - Mediouni, Chouaib / Collaborator ED - Znati, Ali / Collaborator ED - Montanes, Gloria / Collaborator ED - Garcia, Laetitia / Collaborator ED - Thomé, Claudius / Collaborator ED - Breitkopf, Robert / Collaborator ED - Peer, Andreas / Collaborator ED - Lehner, Georg / Collaborator ED - Bellman, Romuald / Collaborator ED - Ditlbacher, Adelheid / Collaborator ED - Finkenstedt, Armin / Collaborator ED - Zotter, Klemens / Collaborator ED - Hernandez, Christian Preuss / Collaborator ED - Rajsic, Sasa / Collaborator ED - Lanthaler, Barbara / Collaborator ED - Greil, Richard / Collaborator ED - Tamás, Kiss / Collaborator ED - Kovácsné-Levang, Szilvia / Collaborator ED - Sipos, David / Collaborator ED - Kappéter, Agnes / Collaborator ED - Halda-Kiss, Bernadett / Collaborator ED - Madarassi-Papp, Edit / Collaborator ED - Hajdú, Edit / Collaborator ED - Bende, Balázs / Collaborator ED - Konstantinos, Thomas / Collaborator ED - Moschopoulos, Charalambos / Collaborator ED - Labrou, Eleni / Collaborator ED - Tsakona, Maria / Collaborator ED - Grigoropoulos, Ioannis / Collaborator ED - Kotanidou, Anastasia / Collaborator ED - Fragkou, Paraskevi / Collaborator ED - Theodorakopoulou, Maria / Collaborator ED - Pantazi, Eugenia / Collaborator ED - Jahai, Edison / Collaborator ED - Moukouli, Maria / Collaborator ED - Siafakas, Dimitrios / Collaborator ED - Mühlbauer, Bernd / Collaborator ED - Dembinski, Rolf / Collaborator ED - Stich, Kathrin / Collaborator ED - Schneider, Gerhard / Collaborator ED - Nagy, Andrej / Collaborator ED - Grodová, Karolína / Collaborator ED - Kubelová, Michaela / Collaborator ED - Součková, Lenka / Collaborator ED - Švábová, Helena Kartáková / Collaborator ED - Demlová, Regina / Collaborator ED - Sonderlichová, Simona / Collaborator ED - Unal, Serhat / Collaborator ED - Inkaya, A C / Collaborator ED - de Bono, Stephanie / Collaborator ED - Kartman, Cynthia E / Collaborator ED - Adams, David H / Collaborator ED - Crowe, Brenda / Collaborator ED - Yazdanapanah, Yazdan / Collaborator ED - Unal, Serhat / Collaborator ED - Schneider, Gerhard / Collaborator ED - Mühlbauer, Bernd / Collaborator ED - Ødegård, Tone / Collaborator ED - Bakkehøi, Gine / Collaborator ED - Autran, Brigitte / Collaborator ED - Bjørås, Magnar / Collaborator ED - Lambellerie, Xavier de- / Collaborator ED - Mezzarri, Fulvia / Collaborator ED - Guedj, Jeremie / Collaborator ED - Esperou, Helene / Collaborator ED - Lumbroso, Julia / Collaborator ED - Welte, Tobias / Collaborator ED - Calmy, Alexandra / Collaborator ED - Pischke, Søren / Collaborator ED - Treweek, Shaun / Collaborator ED - Goetghebeur, Els / Collaborator ED - Doussau, Adelaide / Collaborator ED - Weiss, Laurence / Collaborator ED - Hulstaert, Frank / Collaborator ED - Botgros, Radu / Collaborator ED - Del Alamo, Marta / Collaborator ED - Chung, Florence / Collaborator ED - Lumbroso, Julia / Collaborator ED - Zeitlinger, Markus / Collaborator ED - Escalera, Begonya N / Collaborator ED - Csajka, Chantal / Collaborator ED - Williams, Clare / Collaborator ED - Amstutz, Alain / Collaborator ED - Rüegg, Corina Silvia / Collaborator ED - Burdet, Charles / Collaborator ED - Massonnaud, Clement / Collaborator ED - Belhadi, Drifa / Collaborator ED - Mentré, France / Collaborator ED - Aroun, Massinissa / Collaborator ED - Mentré, France / Collaborator ED - Ehrmann, Stephan / Collaborator ED - Espoerou, Helene / Collaborator ED - Burdet, Charles / Collaborator ED - Falk, Ragnhild Sørum / Collaborator ED - Bjordal, Kristin / Collaborator ED - Bakkehøi, Gina / Collaborator ED - Ødegård, Tone / Collaborator ED - Barratt-Due, Andreas / Collaborator TI - Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct). a randomised, double-blind, placebo-controlled phase 3 trial. TS - a randomised, double-blind, placebo-controlled phase 3 trial. JF - CRITICAL CARE J2 - CRIT CARE VL - 27 PY - 2023 IS - 1 PG - 15 SN - 1364-8535 DO - 10.1186/s13054-022-04205-8 UR - https://m2.mtmt.hu/api/publication/33560025 ID - 33560025 N1 - * Megosztott szerzőség AB - Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants.Bari-SolidAct is a phase-3, multicentre, randomised, double-blind, placebo-controlled trial, enrolling participants from June 3, 2021 to March 7, 2022, stopped prematurely for external evidence. Patients with severe/critical COVID-19 were randomised to Baricitinib 4 mg once daily or placebo, added to standard of care. The primary endpoint was all-cause mortality within 60 days. Participants were remotely followed to day 90 for safety and patient related outcome measures.Two hundred ninety-nine patients were screened, 284 randomised, and 275 received study drug or placebo and were included in the modified intent-to-treat analyses (139 receiving baricitinib and 136 placebo). Median age was 60 (IQR 49-69) years, 77% were male and 35% had received at least one dose of SARS-CoV2 vaccine. There were 21 deaths at day 60 in each group, 15.1% in the baricitinib group and 15.4% in the placebo group (adjusted absolute difference and 95% CI - 0.1% [- 8·3 to 8·0]). In sensitivity analysis censoring observations after drug discontinuation or rescue therapy (tocilizumab/increased steroid dose), proportions of death were 5.8% versus 8.8% (- 3.2% [- 9.0 to 2.7]), respectively. There were 148 serious adverse events in 46 participants (33.1%) receiving baricitinib and 155 in 51 participants (37.5%) receiving placebo. In subgroup analyses, there was a potential interaction between vaccination status and treatment allocation on 60-day mortality. In a subsequent post hoc analysis there was a significant interaction between vaccination status and treatment allocation on the occurrence of serious adverse events, with more respiratory complications and severe infections in vaccinated participants treated with baricitinib. Vaccinated participants were on average 11 years older, with more comorbidities.This clinical trial was prematurely stopped for external evidence and therefore underpowered to conclude on a potential survival benefit of baricitinib in severe/critical COVID-19. We observed a possible safety signal in vaccinated participants, who were older with more comorbidities. Although based on a post-hoc analysis, these findings warrant further investigation in other trials and real-world studies. Trial registration Bari-SolidAct is registered at NCT04891133 (registered May 18, 2021) and EUClinicalTrials.eu ( 2022-500385-99-00 ). LA - English DB - MTMT ER -